Aldeyra Therapeutics Inc
NASDAQ:ALDX
Income Statement
Earnings Waterfall
Aldeyra Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-42.8m
USD
|
Operating Income
|
-42.8m
USD
|
Other Expenses
|
5.3m
USD
|
Net Income
|
-37.5m
USD
|
Income Statement
Aldeyra Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
(9)
|
(10)
|
(12)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(20)
|
(20)
|
(22)
|
(26)
|
(30)
|
(36)
|
(40)
|
(42)
|
(47)
|
(55)
|
(57)
|
(55)
|
(49)
|
(38)
|
(35)
|
(38)
|
(45)
|
(52)
|
(56)
|
(62)
|
(65)
|
(64)
|
(63)
|
(63)
|
(56)
|
(50)
|
(43)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(12)
|
(12)
|
(12)
|
(11)
|
(11)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(13)
|
(13)
|
(15)
|
(17)
|
(17)
|
(16)
|
(13)
|
|
Research & Development |
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(8)
|
(10)
|
(12)
|
(13)
|
(13)
|
(13)
|
(14)
|
(14)
|
(16)
|
(20)
|
(22)
|
(27)
|
(30)
|
(31)
|
(35)
|
(43)
|
(44)
|
(43)
|
(37)
|
(27)
|
(25)
|
(26)
|
(32)
|
(39)
|
(45)
|
(49)
|
(53)
|
(51)
|
(47)
|
(46)
|
(39)
|
(34)
|
(29)
|
|
Operating Income |
(4)
N/A
|
(5)
-26%
|
(5)
-14%
|
(6)
-15%
|
(7)
-19%
|
(8)
-12%
|
(9)
-7%
|
(10)
-16%
|
(12)
-19%
|
(15)
-24%
|
(17)
-14%
|
(18)
-8%
|
(19)
-2%
|
(19)
-1%
|
(20)
-5%
|
(20)
-1%
|
(22)
-12%
|
(26)
-15%
|
(30)
-15%
|
(36)
-20%
|
(40)
-11%
|
(42)
-6%
|
(47)
-11%
|
(55)
-17%
|
(57)
-3%
|
(55)
+2%
|
(49)
+12%
|
(38)
+22%
|
(35)
+9%
|
(38)
-9%
|
(45)
-20%
|
(52)
-16%
|
(56)
-8%
|
(62)
-10%
|
(65)
-5%
|
(64)
+1%
|
(63)
+3%
|
(63)
0%
|
(56)
+12%
|
(50)
+9%
|
(43)
+15%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
17
|
22
|
23
|
13
|
2
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
1
|
2
|
4
|
5
|
5
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
(7)
|
(7)
|
0
|
(0)
|
(0)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
13
N/A
|
17
+33%
|
18
+2%
|
7
-63%
|
(5)
N/A
|
(8)
-49%
|
(9)
-14%
|
(10)
-15%
|
(12)
-19%
|
(15)
-23%
|
(17)
-14%
|
(18)
-8%
|
(19)
-2%
|
(19)
-1%
|
(20)
-5%
|
(20)
-1%
|
(22)
-11%
|
(26)
-15%
|
(29)
-15%
|
(35)
-20%
|
(39)
-10%
|
(47)
-22%
|
(52)
-9%
|
(60)
-15%
|
(62)
-4%
|
(55)
+11%
|
(49)
+11%
|
(39)
+20%
|
(38)
+4%
|
(39)
-4%
|
(47)
-19%
|
(54)
-15%
|
(58)
-7%
|
(63)
-10%
|
(66)
-4%
|
(65)
+2%
|
(62)
+4%
|
(61)
+2%
|
(52)
+14%
|
(46)
+12%
|
(38)
+18%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
13
|
17
|
18
|
7
|
(5)
|
(8)
|
(9)
|
(10)
|
(12)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(20)
|
(20)
|
(22)
|
(26)
|
(29)
|
(35)
|
(39)
|
(46)
|
(50)
|
(58)
|
(61)
|
(55)
|
(49)
|
(39)
|
(38)
|
(39)
|
(46)
|
(53)
|
(58)
|
(63)
|
(66)
|
(65)
|
(62)
|
(61)
|
(52)
|
(46)
|
(38)
|
|
Net Income (Common) |
1
N/A
|
5
+388%
|
(3)
N/A
|
(6)
-84%
|
(10)
-51%
|
(12)
-25%
|
(9)
+26%
|
(10)
-15%
|
(12)
-19%
|
(15)
-23%
|
(17)
-14%
|
(18)
-8%
|
(19)
-2%
|
(19)
-1%
|
(20)
-5%
|
(20)
-1%
|
(22)
-11%
|
(26)
-15%
|
(29)
-15%
|
(35)
-20%
|
(39)
-10%
|
(46)
-19%
|
(50)
-9%
|
(58)
-16%
|
(61)
-4%
|
(55)
+9%
|
(49)
+11%
|
(39)
+20%
|
(38)
+5%
|
(39)
-4%
|
(46)
-19%
|
(53)
-15%
|
(58)
-8%
|
(63)
-10%
|
(66)
-4%
|
(65)
+2%
|
(62)
+4%
|
(61)
+2%
|
(52)
+14%
|
(46)
+12%
|
(38)
+18%
|
|
EPS (Diluted) |
0.18
N/A
|
1.87
+939%
|
-0.57
N/A
|
-1.13
-98%
|
-2.51
-122%
|
-1.78
+29%
|
-1.05
+41%
|
-1.04
+1%
|
-1.4
-35%
|
-1.53
-9%
|
-1.22
+20%
|
-1.47
-20%
|
-1.65
-12%
|
-1.36
+18%
|
-1.3
+4%
|
-1.28
+2%
|
-1.4
-9%
|
-1.32
+6%
|
-1.48
-12%
|
-1.67
-13%
|
-1.79
-7%
|
-1.7
+5%
|
-1.86
-9%
|
-2.17
-17%
|
-2.24
-3%
|
-1.88
+16%
|
-1.63
+13%
|
-1.04
+36%
|
-1.11
-7%
|
-0.85
+23%
|
-0.85
N/A
|
-0.91
-7%
|
-1.07
-18%
|
-1.08
-1%
|
-1.13
-5%
|
-1.11
+2%
|
-1.06
+5%
|
-1.04
+2%
|
-0.89
+14%
|
-0.78
+12%
|
-0.64
+18%
|